Market Intelligence

Sandoz and mAbxience have entered into a licensing, development, manufacturing, and commercialization agreement for a proposed biosimilar to Genentech's HEMLIBRA® (emicizumab), used to treat hemophilia A. This collaboration marks Sandoz's first hemophilia biosimilar and expands its biosimilar pipeline to 40 assets.

Healthcare private equity investors are seeing a new phase of opportunity, with substantial capital available for deployment, improving deal prospects, and accelerating AI adoption reshaping the investment thesis. But growth prospects vary considerably across healthcare sectors, and generating returns will require greater discipline around deal selection, operational execution, and technology investment.

On October 2, 2026, the California Office of Administrative Law approved emergency regulations issued by California’s Office of Health Care Affordability (OHCA) to implement Assembly Bill (AB) 1415 and significantly expand California’s healthcare transaction notice regime. The regulations, which will become effective on November 2, 2026, implement new reporting requirements for management services organizations (MSOs), private equity (PE) groups, hedge funds, and other “noticing entities.” They also establish new reporting triggers for certain PE, MSO, and healthcare real estate transactions and expand the information parties must provide to OHCA.

Baby Loss Awareness Week, observed from 9-15 October, provides a crucial platform for remembering babies lost during pregnancy, at birth, or shortly after, while supporting affected families. This article explores the significance of the awareness campaign, its connection to recent maternity care reviews, and the legal support available to families seeking answers about potential clinical negligence.

On October 23, 2026, the U.S. House Committee on Oversight and Government Reform announced an investigation into whether the three largest pharmacy benefit managers (PBMs)—CVS Caremark, Express Scripts and Optum...

The Centers for Medicare & Medicaid Services (CMS) may be preparing one of the most significant changes to Medicare fraud enforcement in years. Under a newly released draft contractor model...